2004
DOI: 10.1016/j.ijantimicag.2003.07.017
|View full text |Cite
|
Sign up to set email alerts
|

Antimicrobial resistance among non-fermentative Gram-negative bacilli isolated from the respiratory tracts of Italian inpatients: a 3-year surveillance study by the Italian Epidemiological Survey

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
11
0
6

Year Published

2004
2004
2016
2016

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 27 publications
(18 citation statements)
references
References 69 publications
1
11
0
6
Order By: Relevance
“…Isolates from the SENTRY Program, 1997) also had higher susceptibility than ours, and amikacin was the most active compound, but in our work only 26% of the isolates were susceptible to this drug. In Italy, Fadda et al (2004) tested 1474 isolates of P. aeruginosa and observed the most active drug was meropenem (susceptibility rates of 80.7%), only 31.9% of the isolates were fully susceptible and 12.5% were classified as multiresistant isolates. The high resistance rates observed in the present study to gentamicin, amikacin, ciprofloxacin, aztreonam, cephalosporins of third and fourth generation, as well the high resistance to both ceftazidime and cefepime (40%) and to ceftazidime, cefepime and ciprofloxacin (37%) are of special concerning since these drugs are currently used in the treatment of infections caused by P. aeruginosa.…”
Section: Discussionmentioning
confidence: 99%
“…Isolates from the SENTRY Program, 1997) also had higher susceptibility than ours, and amikacin was the most active compound, but in our work only 26% of the isolates were susceptible to this drug. In Italy, Fadda et al (2004) tested 1474 isolates of P. aeruginosa and observed the most active drug was meropenem (susceptibility rates of 80.7%), only 31.9% of the isolates were fully susceptible and 12.5% were classified as multiresistant isolates. The high resistance rates observed in the present study to gentamicin, amikacin, ciprofloxacin, aztreonam, cephalosporins of third and fourth generation, as well the high resistance to both ceftazidime and cefepime (40%) and to ceftazidime, cefepime and ciprofloxacin (37%) are of special concerning since these drugs are currently used in the treatment of infections caused by P. aeruginosa.…”
Section: Discussionmentioning
confidence: 99%
“…Yoğun bakımda acinetobacter enfeksiyonu geliş-mesine neden olan yaş, cinsiyet, yoğun bakımda yatış süreleri, altta yatan hastalıkları, invaziv prosödür uygulanması, transfüzyon öyküsü ve antibiyotik kullanımı gibi birçok risk faktörü tanımlanmıştır (9)(10)(11) . Grupper ve ark.…”
Section: Discussionunclassified
“…Alt solunum yolu infeksiyonları, hastanede yatarak tedavi gören hastalarda önemli morbidite ve mortalite nedenidir (1,2).…”
Section: Introductionunclassified
“…Pseudomonas aeruginosa ve Acinetobacter baumannii başta olmak üzere Gram-negatif bakteriyel patojenler nozokomiyal alt solunum yolu infeksiyonlarının önemli bölümünden sorumludurlar (1)(2)(3).…”
Section: Introductionunclassified